Therapies for mobility disability in persons with multiple sclerosis

JF Baird, BM Sandroff, RW Motl - Expert review of …, 2018 - Taylor & Francis
Introduction: Mobility disability is one of the most widespread and impactful consequences of
multiple sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of …
被引用次数：76 相关文章
[HTML] nih.gov

[HTML][HTML] Therapies for mobility disability in persons with multiple sclerosis

JF Baird, BM Sandroff, RW Motl - Expert review of …, 2018 - ncbi.nlm.nih.gov
Introduction: Mobility disability is one of the most widespread and impactful consequences of
multiple sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of …

Therapies for mobility disability in persons with multiple sclerosis

JF Baird, BM Sandroff, RW Motl - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Mobility disability is one of the most widespread and impactful consequences of multiple
sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of disability …

Therapies for mobility disability in persons with multiple sclerosis.

JF Baird, BM Sandroff, RW Motl - Expert Review of …, 2018 - europepmc.org
Introduction: Mobility disability is one of the most widespread and impactful consequences of
multiple sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of …